| PERIOD ENDING | 4-Apr-09 | 31-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 5,371,000 | 7,136,000 | 7,480,000 | 8,082,000 | | Cost of Revenue | 3,875,000 | 5,014,000 | 5,677,000 | 5,757,000 | | | Gross Profit | 1,496,000 | 2,122,000 | 1,803,000 | 2,325,000 | | | Operating Expenses | | Research Development | 847,000 | 1,008,000 | 999,000 | 1,048,000 | | Selling General and Administrative | 869,000 | 988,000 | 710,000 | 1,449,000 | | Non Recurring | 229,000 | 2,045,000 | 302,000 | (94,000) | | Others |
-
| (244,000) | 244,000 | (83,000) | | | | Total Operating Expenses |
-
| 3,797,000 | 2,255,000 | 2,320,000 | | | | Operating Income or Loss | (449,000) | (1,675,000) | (452,000) | 5,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 77,000 | (30,000) | (96,000) | 18,000 | | Earnings Before Interest And Taxes | (372,000) | (1,705,000) | (548,000) | 23,000 | | Interest Expense | 62,000 | 20,000 | 52,000 | 74,000 | | Income Before Tax | (434,000) | (1,725,000) | (600,000) | (51,000) | | Income Tax Expense | (146,000) | 1,932,000 | (203,000) | (55,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (288,000) | (3,657,000) | (397,000) | 4,000 | | | Non-recurring Events | | Discontinued Operations | 60,000 |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (228,000) | (3,657,000) | (397,000) | 4,000 | | Preferred Stock And Other Adjustments | (3,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($231,000) | ($3,657,000) | ($397,000) | $4,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
